MediFind

Find a Doctor

Stephen P. Mulligan

Royal North Shore Hospital
Male

Bio


Stephen Mulligan is in Sydney, Australia. They have been an author on 70 peer reviewed articles in the past 15 years. Dr. Mulligan's top three areas of expertise are Chronic Lymphocytic Leukemia, Chronic B-Cell Leukemia, and Leukemia.

Contact

Sydney, NSW, AU

Latest Research


Latest Advance
Study
  • Condition: Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
  • Journal: American journal of hematology
  • Treatment Used: Ibrutinib
  • Number of Patients: 0
  • Published —
This study tested the safety and efficacy of using ibrutinib to treat patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Latest Advance
Study
  • Condition: Chronic Lymphocytic Leukemia (CLL)
  • Journal: Blood
  • Treatment Used: Ibrutinib vs Ofatumumab
  • Number of Patients: 0
  • Published —
This study compared the effectiveness and safety of ibrutinib versus ofatumumab in patients with chronic lymphocytic leukemia (type of cancer in which the bone marrow makes too many lymphocytes; CLL).
Latest Advance
Study
  • Condition: Chronic Lymphocytic Leukemia or Lymphoma
  • Journal: Clinical lymphoma, myeloma & leukemia
  • Treatment Used: Ibrutinib or Ofatumumab
  • Number of Patients: 391
  • Published —
This study compared the clinical outcome of using ibrutinib or ofatumumab to treat patients with chronic lymphocytic leukemia or lymphoma that were previously treated.

Clinical Trials


This doctor has not participated in any recent clinical trials.

All Publications
View All


Contact

Sydney, NSW, AU

Insurance

Contact them to find out if they accept your insurance plan.